152 related articles for article (PubMed ID: 29542019)
1. In Vivo Red Blood Cells/Plasma Partition Coefficient of Treosulfan and Its Active Monoepoxide in Rats.
Romański M; Zacharzewska A; Teżyk A; Główka FK
Eur J Drug Metab Pharmacokinet; 2018 Oct; 43(5):565-571. PubMed ID: 29542019
[TBL] [Abstract][Full Text] [Related]
2. Disposition of treosulfan and its active monoepoxide in a bone marrow, liver, lungs, brain, and muscle: Studies in a rat model with clinical relevance.
Romański M; Kasprzyk A; Walczak M; Ziółkowska A; Główka F
Eur J Pharm Sci; 2017 Nov; 109():616-623. PubMed ID: 28916482
[TBL] [Abstract][Full Text] [Related]
3. Formation Rate-Limited Pharmacokinetics of Biologically Active Epoxy Transformers of Prodrug Treosulfan.
Romański M; Kasprzyk A; Karbownik A; Szałek E; Główka FK
J Pharm Sci; 2016 May; 105(5):1790-1797. PubMed ID: 27044946
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of treosulfan and its active monoepoxide in pediatric patients after intravenous infusion of high-dose treosulfan prior to HSCT.
Główka F; Kasprzyk A; Romański M; Wróbel T; Wachowiak J; Szpecht D; Kałwak K; Wiela-Hojeńska A; Dziatkiewicz P; Teżyk A; Żaba C
Eur J Pharm Sci; 2015 Feb; 68():87-93. PubMed ID: 25527118
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic approach for evaluation of treosulfan and its active monoepoxide disposition in plasma and brain on the basis of a rat model.
Danielak D; Romański M; Kasprzyk A; Teżyk A; Główka F
Pharmacol Rep; 2020 Oct; 72(5):1297-1309. PubMed ID: 32474888
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a High Pressure Liquid Chromatography-UV Method for the Determination of Treosulfan and Its Epoxy Metabolites in Human Plasma and Its Application in Pharmacokinetic Studies.
Koyyalamudi SR; Kuzhiumparambil U; Nath CE; Byrne JA; Fraser CJ; O'Brien TA; Earl JW; Shaw PJ
J Chromatogr Sci; 2016 Mar; 54(3):326-33. PubMed ID: 26433392
[TBL] [Abstract][Full Text] [Related]
7. Treosulfan Pharmacokinetics and its Variability in Pediatric and Adult Patients Undergoing Conditioning Prior to Hematopoietic Stem Cell Transplantation: Current State of the Art, In-Depth Analysis, and Perspectives.
Romański M; Wachowiak J; Główka FK
Clin Pharmacokinet; 2018 Oct; 57(10):1255-1265. PubMed ID: 29557088
[TBL] [Abstract][Full Text] [Related]
8. Rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of protein-free pro-drug treosulfan and its biologically active monoepoxy-transformer in plasma and brain tissue.
Romański M; Teżyk A; Zaba C; Główka FK
Talanta; 2014 Sep; 127():123-32. PubMed ID: 24913866
[TBL] [Abstract][Full Text] [Related]
9. Clinical bioanalysis of treosulfan and its epoxides: The importance of collected blood processing for valid pharmacokinetic results.
Romański M; Główka F
J Pharm Biomed Anal; 2018 May; 153():199-203. PubMed ID: 29501039
[TBL] [Abstract][Full Text] [Related]
10. Determination of prodrug treosulfan and its biologically active monoepoxide in rat plasma, liver, lungs, kidneys, muscle, and brain by HPLC-ESI-MS/MS method.
Romański M; Kasprzyk A; Teżyk A; Widerowska A; Żaba C; Główka F
J Pharm Biomed Anal; 2017 Jun; 140():122-129. PubMed ID: 28346882
[TBL] [Abstract][Full Text] [Related]
11. Determination of treosulfan in plasma and urine by HPLC with refractometric detection; pharmacokinetic studies in children undergoing myeloablative treatment prior to haematopoietic stem cell transplantation.
Główka FK; Łada MK; Grund G; Wachowiak J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):569-74. PubMed ID: 17210272
[TBL] [Abstract][Full Text] [Related]
12. Determination of partition coefficients n-octanol/water for treosulfan and its epoxy-transformers: an example of a negative correlation between lipophilicity of unionized compounds and their retention in reversed-phase chromatography.
Główka FK; Romański M; Siemiątkowska A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 923-924():92-7. PubMed ID: 23500352
[TBL] [Abstract][Full Text] [Related]
13. Ocular disposition of treosulfan and its active epoxy-transformers following intravenous administration in rabbits.
Romański M; Kasprzyk A; Karbownik A; Główka FK
Drug Metab Pharmacokinet; 2016 Oct; 31(5):356-362. PubMed ID: 27662779
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT.
Główka FK; Karaźniewicz-Łada M; Grund G; Wróbel T; Wachowiak J
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S67-70. PubMed ID: 18978748
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatography-tandem mass spectrometry method for simultaneous determination of three N-7-guanine adducts of the active epoxides of prodrug treosulfan in DNA in vitro.
Romański M; Rotecki K; Nowicki B; Teżyk A; Główka FK
Talanta; 2019 Jun; 198():464-471. PubMed ID: 30876588
[TBL] [Abstract][Full Text] [Related]
16. Penetration of Treosulfan and its Active Monoepoxide Transformation Product into Central Nervous System of Juvenile and Young Adult Rats.
Romański M; Baumgart J; Böhm S; Główka FK
Drug Metab Dispos; 2015 Dec; 43(12):1946-54. PubMed ID: 26428246
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors.
Hilger RA; Harstrick A; Eberhardt W; Oberhoff C; Skorzec M; Baumgart J; Seeber S; Scheulen ME
Cancer Chemother Pharmacol; 1998; 42(2):99-104. PubMed ID: 9654108
[TBL] [Abstract][Full Text] [Related]
18. Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer.
Hilger RA; Jacek G; Oberhoff C; Kredtke S; Baumgart J; Seeber S; Scheulen ME
Cancer Chemother Pharmacol; 2000; 45(6):483-8. PubMed ID: 10854136
[TBL] [Abstract][Full Text] [Related]
19. Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
Werner S; Mendoza A; Hilger RA; Erlacher M; Reichardt W; Lissat A; Konanz C; Uhl M; Niemeyer CM; Khanna C; Kontny U
Cancer Chemother Pharmacol; 2008 Jun; 62(1):19-31. PubMed ID: 17823799
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantation.
Danielak D; Twardosz J; Kasprzyk A; Wachowiak J; Kałwak K; Główka F
Eur J Clin Pharmacol; 2018 Jan; 74(1):79-89. PubMed ID: 28975382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
